EUVIMEDEUVIMED entdecken
Crossref

Juxtamembrane Mimic Peptide Loaded Injectable Sodium Alginate/Bioglass Bioactive Hydrogel for Suppressing Tumor Recurrence in Post-Breast-Conserving-Surgery Treatment

Yiping Fan, Qi Han iD, Arpita Poddar, Rodney Luwor, Yiran Zhang, Aparna Jayachandran, Brendan P Dyett iD, San H Thang iD, Calum J Drummond iD, Jiali Zhai iD, Haiyan Li iD

ACS Applied Bio Materials · 17.08.2026 · 9 (16) · 7243-7256

DOI: 10.1021/acsabm.5c02571 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 25.07.2026. Verfasst von Yiping Fan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Assembly Lab, School of Science, STEM College, RMIT University, Melbourne, Victoria3000, Australia. Hauptthemen laut MEDLINE: Alginates, Hydrogels, Breast Neoplasms, Peptides. Die Arbeit nennt 69 Literaturangaben. Gefördert von: Cass Foundation, Australian Research Council (ARC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer remains the most diagnosed tumor among women worldwide, and tumor recurrence following breast-conserving surgery presents a major clinical challenge. To address this, we developed a functional injectable sodium alginate/bioactive glass (SA/BG) hydrogel loaded with a juxtamembrane-2 (JM2) mimic peptide (JM2@SA/BG) for breast tumor postsurgical treatment. The hydrogel exhibited rapid in situ gelation, tunable swelling, and mechanical strength well-matched to natural breast tissue, with JM2 incorporation increasing crosslinking density through ionic and hydrogen bonding. A sustained, diffusion-controlled release of JM2 was achieved by encapsulating JM2 into the SA/BG hydrogel, which was consistent with the Higuchi model, ensuring prolonged therapeutic bioavailability. In vitro, JM2 exhibited a selective inhibition on 4T1 breast cancer cells (IC50 = 65 μg/mL) while maintaining high biocompatibility with fibroblasts. In vivo, with a murine breast cancer postsurgery model, the JM2@SA/BG hydrogel significantly suppressed tumor recurrence, evidenced by the reduced Ki67-positive proliferating cells, increased TUNEL-positive apoptotic cells, and nuclear abnormalities in the remaining tumor tissue demonstrated by H&E staining. Collectively, these results highlight the JM2@SA/BG hydrogel as a promising injectable and functional platform that provides spatiotemporal control of drug delivery, possesses localized anticancer activity, and offers an effective strategy to suppress tumor recurrence in breast cancer postsurgery therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlginatesHydrogelsBreast NeoplasmsPeptidesAntineoplastic AgentsBiocompatible MaterialsNeoplasm Recurrence, LocalAnimalsFemaleMiceCell ProliferationMastectomy, SegmentalMaterials TestingMice, Inbred BALB CHumansDrug Screening Assays, AntitumorParticle SizeCarbonatesSilicon DioxidePhosphorus Compounds

Stichwörter der Autor:innen

Juxtamembrane 2antitumor recurrencebioactive glassbreast tumorhydrogelpostsurgery treatmentsodium alginate

Substanzen

AlginatesHydrogelsPeptidesAntineoplastic AgentsBiocompatible MaterialsBioglassCarbonatesSilicon DioxidePhosphorus Compounds

Autor:innen und Institutionen

  • Molecular Assembly Lab, School of Science, STEM College, RMIT University, Melbourne, Victoria3000, Australia.
  • School of Science, RMIT University, Melbourne, Victoria3000, Australia.
  • Fiona Elsey Cancer Research Institute , Ballarat, Victoria3353, Australia.
  • Health and Innovation Transformation Centre, Federation University, Ballarat, Victoria3353, Australia.
  • Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville, Victoria3050, Australia.
  • Huagene Institute, Kecheng Science and Technology Park, Pukou District, Nanjing211806, Jiangsu, China.

ORCID-Profile: Qi Han, Brendan P Dyett, San H Thang, Calum J Drummond, Jiali Zhai, Haiyan Li

Förderung

  • Cass Foundation
  • Australian Research Council (ARC)

Zitieren

APA

Fan, Y., Han, Q., Poddar, A., Luwor, R., Zhang, Y., Jayachandran, A., Dyett, B. P., Thang, S. H., Drummond, C. J., Zhai, J., & Li, H. (2026). Juxtamembrane Mimic Peptide Loaded Injectable Sodium Alginate/Bioglass Bioactive Hydrogel for Suppressing Tumor Recurrence in Post-Breast-Conserving-Surgery Treatment. ACS Applied Bio Materials, 9(16), 7243-7256. https://doi.org/10.1021/acsabm.5c02571

Vancouver

Fan Y, Han Q, Poddar A, Luwor R, Zhang Y, Jayachandran A, et al. Juxtamembrane Mimic Peptide Loaded Injectable Sodium Alginate/Bioglass Bioactive Hydrogel for Suppressing Tumor Recurrence in Post-Breast-Conserving-Surgery Treatment. ACS Applied Bio Materials. 2026;9(16):7243-7256. doi:10.1021/acsabm.5c02571

BibTeX
@article{Fan2026,
  author = {Fan, Yiping and Han, Qi and Poddar, Arpita and Luwor, Rodney and Zhang, Yiran and Jayachandran, Aparna and Dyett, Brendan P and Thang, San H and Drummond, Calum J and Zhai, Jiali and Li, Haiyan},
  title = {Juxtamembrane Mimic Peptide Loaded Injectable Sodium Alginate/Bioglass Bioactive Hydrogel for Suppressing Tumor Recurrence in Post-Breast-Conserving-Surgery Treatment},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  volume = {9},
  number = {16},
  pages = {7243--7256},
  doi = {10.1021/acsabm.5c02571}
}
Kostenlos starten →